Multicellular resistance: Another mechanism for multidrug resistance?;La resistance multicellulaire: Un autre mecanisme de resistance pleiotropique?

Bulletin du Cancer

Volumn 85, Issue 9, 1998, Pages 785-793

  Desoize, Bernard ^a   Gimonet, Delphine ^a   Jardillier, Jean Claude ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

Author keywords

Metastasis; Multicellular resistance; Multidrug resistance (MDR); P glycoprotein; Spheroids

Indexed keywords

4' IODOESORUBICIN; ANTINEOPLASTIC AGENT; CHLORAMBUCIL; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GLYCOPROTEIN P; LOMUSTINE; METHOTREXATE; MITOMYCIN; MITOXANTRONE; PACLITAXEL; VALSPODAR; VINBLASTINE; VINCRISTINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; EXTRACELLULAR MATRIX; GROWTH INHIBITION; HUMAN; HUMAN CELL; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; SPHEROID CELL; TUMOR GROWTH; CELL CYCLE; DRUG EFFECT; DRUG RESISTANCE; METASTASIS; MULTICELLULAR SPHEROID; PATHOLOGY;

CELL CYCLE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; EXTRACELLULAR MATRIX; NEOPLASM METASTASIS; SPHEROIDS, CELLULAR;

EID: 0031764462     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Carlsson J, Nilsson K, Westermark B, Ponten J, Sundstrom C, Larsson E et al. Formation and growth of multicellular spheroids of human origin. Int J Cancer 1983 ; 31 : 523-33.
2. Kerbel RS, Rak J, Kobayashi H, Man MS, St Croix B, Graham CH. Multicellular resistance: a new paradigm to explain aspects of acquired drug resistance of solid tumors. Cold Spring Harb Symp Quant Biol 1994 ; 59 : 661-72.
3. Bates RC, Buret A, van Helden DF, Horton MA, Burns GF. Apoptosis induced by inhibition of intercellular contact. J Cell Biol 1994 ; 125 : 403-15.
4. Carlsson J, Brunk U. The fine structure of three-dimensional colonies of human glioma cells in agarose culture. Acta Pathol Microbiol Scand [A] 1977 ; 85A : 183-92.
5. Sutherland RM. Cell and environment interactions in tumor micro-regions: the multicell spheroid model. Science 1988 ; 240 : 177-84.
6. Mattern J, Kallinowski F, Herfarth C, Volm M. Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer. Int J Cancer 1996 ; 67 : 20-3.
7. Sutherland RM, Sordat B, Bamat J, Gabbert H, Bourrat B, Mueller-Klieser W. Oxygenation and differentiation in multicellular spheroids of human colon carcinoma. Cancer Res 1986 ; 46 : 5320-9.
8. Waleh NS, Brody MD, Knapp MA, Mendonca HL, Lord EM, Koch CJ et al. Mapping of the vascular endothelial growth factor-producing hypoxic cells in multicellular tumor spheroids using a hypoxia-specific marker. Cancer Res 1995 ; 55 : 6222-6.
9. Mansbridge JN, Ausserer WA, Knapp MA, Sutherland RM. Adaptation of EGF receptor signal transduction to three-dimensional culture conditions: changes in surface receptor expression and protein tyrosine phosphorylation. J Cell Physiol 1994 ; 161 : 374-82.
10. Durand RE. Use of Hoechst 33342 for cell selection from multicell systems. J Histochem Cytochem 1982 ; 30 : 117-22.
11. Landry J, Freyer JP, Sutherland RM. Shedding of mitotic cells from the surface or multicell spheroids during growth. J Cell Physiol 1981 ; 106 : 23-32.
12. Durand RE. Cell cycle kinetics in an in vitro tumor model. Cell Tissue Kinet 1976 ; 9 : 403-12.
13. St Croix B, Florenes VA, Rak JW, Flanagan M, Bhattacharya N, Slingerland JM et al. Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nature Med 1996 ; 2 : 1204-10.
14. Glimelius B, Norling B, Nederman T, Carlsson J. Extracellular matrices in multicellular spheroids of human glioma origin: increased incorporation of proteoglycans and fibronectin as compared to monolayer cultures. APMIS 1988 ; 96 : 43344.
15. Nakagawa T, Kubota T, Kabuto M, Kodera T. Hyaluronic acid facilitates glioma cell invasion in vitro. Anticancer Res 1996 ; 16 : 2917-22.
16. Wilkinson CR, Bower LM, Warren C. The relationship between hyaluronidase activity and hyaluronic acid concentration in sera from normal controls and from patients with disseminated neoplasm. Clin Chim Acta 1996 ; 256 : 165-73.
17. St Croix B, Rak JW, Kapitain S, Sheehan C, Graham CH, Kerbel RS. Reversal by hyaluronidase of adhesion-dependent multicellular drug resistance in mammary carcinoma cells. J Natl Cancer Inst 1996 ; 88 : 1285-96.
18. Chun MH. Plasmin induces the formation of multicellular spheroids of breast cancer cells. Cancer Lett 1997 ; 117 : 51-6.
19. Kobayashi H, Gotoh J, Kanayama N, Hirashima Y, Terao T, Sugino D. Inhibition of tumor cell invasion through matrigel by a peptide derived from the domain II region m urinary trypsin inhibition. Cancer Res 1995 ; 55 : 1847-52.
20. Tofilon PJ, Arundel CM, Deen DF. Response to BCNU of spheroids grown from mixtures of drug-sensitive and drug-resistant cells. Cancer Chemother Pharmacol 1987 ; 20 : 89-95.
21. Graham CH, Kobayashi H, Stankiewicz KS, Man S, Kapitain SJ, Kerbel RS. Rapid acquisition of multicellular drug resistance after a single exposure of mammary tumor cells to antitumor alkylating agents. J Natl Cancer Inst 1994 ; 86 : 975-82.
22. Fujita N, Kataoka S, Naito M, Heike Y, Boku N, Nakajima M, Tsuruo T. Suppression of T-lymphoma cell apoptosis by monoclonal antibodies raised against cell surface adhesion molecules. Cancer Res 1993 ; 53 : 5022-7.
23. Schuetz JD, Schuetz EG. Extracellular matrix regulation of multidrug resistance in primary monolayer cultures of adult rat hepatocytes. Cell Growth Differ 1993 ; 4 : 3140.
24. Montgomery AM, Reisfeld RA, Cheresh DA. Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 1994 ; 91 : 8856-60.
25. Kim WH, Schnaper HW, Nomizu M, Yamada Y, Kleinman HK. Apoptosis in human fibrosarcoma cells is induced by a multimeric synthetic Tyr-Ile-Gly-Ser-Arg (YIGSR)-containing polypeptide from laminin. Cancer Res 1994 ; 54 : 5005-10.
26. Kobayashi H, Man S, Graham CH, Kapitain SJ, Teicher BA, Kerbel RS. Acquired multicellular-mediated resistance to alkylating agents in cancer. Proc Natl Acad Sci USA 1993 ; 90 : 3294-8.
27. Kaaijk P, Troost D, de Boer OJ, Van Amstel P, Bakker PJ, Leenstra S, Bosch DA. Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas. Br J Cancer 1996 ; 74 : 187-93.
28. Olive PL, Durand RE. Drug and radiation resistance in spheroids: cell contact and kinetics. Cancer Metastasis Rev 1994 ; 13 : 121-38.
29. Durand RE. Adriamycin: a possible indirect radiosensitizer of hypoxic tumor cells. Radiology 1976 ; 119 : 217-22.
30. Durand RE, Vanderbyl SL. Tumor resistance to therapy: a genetic or kinetic problem ? Cancer Commun 1989 ; 1 : 277-83.
31. Nicholson KM, Bibby MC, Phillips RM. Influence of drug exposure parameters on the activity of paclitaxel in multicellular spheroids. Eur J Cancer 1997 ; 33 : 1291-8.
32. Dimanche-Boitrel MT, Genne P, Duchamp O, Chauffert B. Confluence dependent resistance (CDR) to doxorubicin and E-cadherin expression in murine mammary cells. Cancer Lett 1994 ; 85 : 171-6.
33. Gorlach A, Herter P, Hentschel H, Frosch PJ, Acker H. Effects of nIFNβ and rIFNγ on growth and morphology of two human melanoma cell lines: comparison between 2- and 3-dimensional culture. Int J Cancer 1994 ; 56 : 249-54.
34. Pedro D, Beltran PJ, Wang YF, Bucana CD, Yoon SS, Deguzman ACP, Fidler IJ. Cell density-dependent regulation of mdr-1 gene expression in murine colon cancer cells. Int J Oncol 1996 ; 9 : 865-78.
35. Sakata K, Kwok TT, Gordon GR, Waleh NS, Sutherland RM. Resistance to verapamil sensitization of multidrug-resistant cells grown as multicellular spheroids. Int J Cancer 1994 ; 59 : 282-6.
36. Durand RE. Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro. Cancer Res 1981 ; 41 : 3495-8.
37. Kolchinsky A, Roninson IB. Drug resistance conferred by MDR1 expression in spheroids formed by glioblastoma cell lines. Anticancer Res 1997 ; 17 : 3321-7.
38. Ehrlich PH, Moustafa ZA, Archinal-Mattheis AE, Newman MJ, Bair KW, Cohen D. The reversal of multidrug resistance in multicellular tumor spheroids by SDZ PSC 833. Anticancer Res 1997 ; 17 : 129-33.
39. Sakata K, Kwok TT, Murphy BJ, Laderoute KR, Gordon GR, Sutherland RM. Hypoxia-induced drug resistance: comparison to P-glycoprotein-associated drug resistance. Br J Cancer 1991 ; 64 : 809-14.
40. Nederman T, Carlsson J, Kuoppa K. Penetration of substances into tumour tissue. Model studies using saccharides, thymidine and thymidine-5′-triphosphate in cellular spheroids. Cancer Chemother Pharmacol 1988 ; 22 : 21-5.
41. Carlsson J, Daniel-Szolgay E, Frykholm G, Glimelius B, Hedin A, Larsson B. Homogeneous penetration but heterogeneous binding of antibodies to carcinoembryonic antigen in human colon carcinoma HT-29 spheroids. Cancer Immunol Immunother 1989 ; 30 : 269-76.
42. Kerr DJ, Wheldon TE, Hydns S, Kaye SB. Cytotoxic drug penetration studies in multicellular tumour spheroids. Xenobiotica 1988 ; 18 : 641-8.
43. Durand RE. Slow penetration of anthracyclines into spheroids and tumors: a therapeutic advantage? Cancer Chemother Pharmacol 1990; 26 : 198-204.
44. Luo C, MacPhail SH, Dougherty GJ, Naus CC, Olive PL. Radiation response of connexin43-transfected cells in relation to the "contact effect". Exp Cell Res 1997 ; 234 : 225-32.
45. Durand RE. Tumor repopulation during radiotheraphy: quantitation in two xenografted human tumors. Int J Radiat Oncol Biol Phys 1997; 39 : 803-8.
46. Desoize B. Anticancer drug resistance and inhibition of apoptosis. Anticancer Res 1994 ; 14 : 2291-4.
47. Raff MC. Social controls on cell survival and cell death. Nature 1992 ; 356 : 397-400.
48. Zhang Z, Vuori K, Reed JC, Ruoslahti E. The α5 β1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA 1995 ; 92 : 6161-5.
49. French LE, Wohlwend A, Sappino AP, Tschopp J, Schifferli JA. Human clusterin gene expression is confined to surviving cells during in vitro programmed cell death. J. Clin Invest 1994 ; 93 : 877-84.
50. Smith KJ, Skelton HG, Turiansky G, Wagner KF. Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma. J Am Acad Dermatol 1997 ; 36 : 239-42.
51. Huang YW, Baluna R, Vitetta ES. Adhesion molecules as targets for cancer therapy. Histol Histopathol 1997 ; 12 : 467-77.
52. Rasmussen HS, McCann PP. Matrix metalloproteinase inhibition as a novel anticancer strategy: a review with special focus on batimastat and marimastat. Pharmacol Ther 1997 ; 75 : 69-75.
53. Liotta LA, Saidel MG, Kleinerman J. The significance of hematogenous tumor cell clumps in the metastatic process. Cancer Res 1976 ; 36 : 889-94.
54. Cifone MA, Fidler IJ. Correlation of patterns of anchorage-independent growth with in vivo behavior of cells from a murine fibrosarcoma. Proc Natl Acad Sci USA 1980 ; 77 : 1039-43.
55. Yoneda J, Saiki I, Kobayashi H, Fujii H, Ishizaki Y, Kato I et al. Inhibitory effect of recombinant fibronectin polypeptides on the adhesion of liver-metastatic lymphoma cells to hepatic sinusoidal endothelial cells and tumor invasion. Jpn J Cancer Res 1994 ; 85 : 723-34.
56. Saiki I, Yoneda J, Igarashi Y, Aoki M, Kusunose N, Ono K, Azuma I. Antimetastatic activity of polymeric RGDT peptides conjugated with poly(ethylene glycol). Jpn J Cancer Res 1993 ; 84 : 558-65.
57. Pilkington CJ. The role of the extracellular matrix in neoplastic glial invasion of the nervous system. Braz J Med Biol Res 1996 ; 29 : 1159-72.
58. Eccles SA, Box GM, Court WJ, Bone EA, Thomas W, Brown PD. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res 1996 ; 56 : 2815-22.
59. Brooks PC, Montgomery AM, Rosenfeld M, Reisfeld RA, Hu T, Klier G, Cheresh DA. Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 1994 ; 79 : 1157-64.